Fard N, Marzocchi G, Storto G, Ghedini P, Palumbo A, Fanti S, Cavo M. 18F-FDG PET/CT
focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active
disease. Leukemia. 2016 Feb;30(2):417-22. doi: 10.1038/leu.2015.291. Epub 2015 Oct 22.
PMID: 26490489.
6. Dykstra BL, Kumar S, Dispenzieri A, Lacy MQ, Buadi F, Dingli D et al. PET/CT has major
diagnostic value in the evaluation of smoldering multiple myeloma. Blood 2014; 124: 3382
Abstract.
7. Ahn IE, Mailankody S, Korde N, Landgren O . Dilemmas in treating smoldering multiple
myeloma. J Clin Oncol 2015; 33: 115–123.
